Letters
Diagnosing prostate cancer in asymptomatic patients
Authors’ reply to Booth and colleagues
BMJ 2022; 378 doi: https://doi.org/10.1136/bmj.o1719 (Published 13 July 2022) Cite this as: BMJ 2022;378:o1719
- Stephen H Bradley, clinical research fellow and GP1,
- Garth Funston, National Institute for Health and Care Research (NIHR) academic clinical fellow2,
- Daniel Jones, NIHR academic clinical lecturer1,
- Jessica Watson, NIHR academic clinical lecturer3
- 1University of Leeds, Leeds, UK
- 2University of Manchester, Manchester, UK
- 3University of Bristol, Bristol, UK
- medsbra{at}leeds.ac.uk
We thank Booth and colleagues for their comments.1 As we outlined in our editorial,2 we agree that the use of magnetic resonance imaging has been an important development which has reduced the need for biopsy along with its associated harms. While we did not offer an opinion as to whether a programme …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.